The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soler, D.
Right arrow Articles by Kolbeck, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soler, D.
Right arrow Articles by Kolbeck, R.
The Journal of Immunology, 2006, 177: 6940-6951.
Copyright © 2006 by The American Association of Immunologists, Inc.

CCR8 Expression Identifies CD4 Memory T Cells Enriched for FOXP3+ Regulatory and Th2 Effector Lymphocytes

Dulce Soler1, Tobias R. Chapman, Louis R. Poisson, Lin Wang, Javier Cote-Sierra, Mark Ryan, Alice McDonald, Sunita Badola, Eric Fedyk, Anthony J. Coyle2, Martin R. Hodge and Roland Kolbeck3

Inflammation, Millennium Pharmaceuticals, Cambridge, MA 02139

CD4+ Th2 cells are important regulators of allergic inflammation. CCR8 is thought to play a role in Th2-mediated responses, however, expression of CCR8 in peripheral blood has not been fully characterized. Using a fluorescent form of the ligand selective for CCR8 (F-CCL1), we identified the leukocytes expressing CCR8 in human, monkey, and mouse peripheral blood. CCR8 expression is primarily restricted to a subset of human CD4 memory T lymphocytes (15%). Approximately 40% of CCR8+CD4+ T cells express Th2 cytokines IL-4 or IL-13 while 13% express the Th1 cytokine IFN-{gamma}. In fact, 50% of all Th2, but only 5% of Th1, cells express CCR8. Upon anti-CD3/anti-CD28 mAb-mediated activation, CCR8+CD4+ T cells secrete 3- to 7-fold higher levels of IL-4, IL-5, IL-9, and IL-13 and 10- to 20-fold lower levels of IFN-{gamma} or IL-17, compared with CCR8CD4+ memory T cells. Two-thirds of CCR8+CD4 T cells express cutaneous lymphocyte-associated Ag while the majority lack gut-homing receptors. CCR8+CD4+ cells express CCR7 and CD62L and are present in spleen and lymph nodes of mice. Approximately 25% of CCR8+CD4 T cells express CD25high while 20% of CCR8+CD4+ express the T regulatory cell transcription factor FOXP3 accounting for 60% of all FOXP3-expressing CD4+ T cells. In conclusion, CCR8 marks a diverse subset of CD4 memory T cells enriched for T regulatory and Th2 cells which have the potential for recruitment into sites of allergic inflammation where they could participate in the induction and regulation of the allergic response.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Address correspondence and reprint requests to Dr. Dulce Soler, Millennium Pharmaceuticals, 35 Landsdowne Street, Cambridge, MA 02139. E-mail address: dsoler{at}mpi.com

2 Current address: Peptimmune, 64 Sidney Street, Cambridge, MA 02139.

3 Abbreviations used in this paper: TNPM, nonpolarized memory T cell; TCM, central memory T cell; TEM, effector memory T cell; TREG, regulatory T cell; CLA, cutaneous lymphoid-associated Ag; F-CCL1, fluorescently labeled CCL-1; DAPI, 4',6'-diamidino-2-phenylindole.

4 Current address: MedImmune, One MedImmune Way, Gaithersburg, MD 20878.




This article has been cited by other articles:


Home page
Arch NeurolHome page
S. Cepok, H. Schreiber, S. Hoffmann, D. Zhou, O. Neuhaus, G. von Geldern, S. Hochgesand, S. Nessler, V. Rothhammer, M. Lang, et al.
Enhancement of Chemokine Expression by Interferon Beta Therapy in Patients With Multiple Sclerosis
Arch Neurol, October 1, 2009; 66(10): 1216 - 1223.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Isaacman-Beck, E. A. Hermann, Y. Yi, S. J. Ratcliffe, J. Mulenga, S. Allen, E. Hunter, C. A. Derdeyn, and R. G. Collman
Heterosexual Transmission of Human Immunodeficiency Virus Type 1 Subtype C: Macrophage Tropism, Alternative Coreceptor Use, and the Molecular Anatomy of CCR5 Utilization
J. Virol., August 15, 2009; 83(16): 8208 - 8220.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D Goven, A Boutten, V Lecon-Malas, J Marchal-Somme, N Amara, B Crestani, M Fournier, G Leseche, P Soler, J Boczkowski, et al.
Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema
Thorax, October 1, 2008; 63(10): 916 - 924.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Mira, B. Leon, D. F. Barber, S. Jimenez-Baranda, I. Goya, L. Almonacid, G. Marquez, A. Zaballos, C. Martinez-A., J. V. Stein, et al.
Statins Induce Regulatory T Cell Recruitment via a CCL1 Dependent Pathway
J. Immunol., September 1, 2008; 181(5): 3524 - 3534.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
A. Linden
A Role for the Cytoplasmic Adaptor Protein Act1 in Mediating IL-17 Signaling
Sci. Signal., August 7, 2007; 2007(398): re4 - re4.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. Nummer, E. Suri-Payer, H. Schmitz-Winnenthal, A. Bonertz, L. Galindo, D. Antolovich, M. Koch, M. Buchler, J. Weitz, V. Schirrmacher, et al.
Role of Tumor Endothelium in CD4+CD25+ Regulatory T Cell Infiltration of Human Pancreatic Carcinoma
J Natl Cancer Inst, August 1, 2007; 99(15): 1188 - 1199.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-A. Gonzalo, Y. Qiu, J. M. Lora, A. Al-Garawi, J.-L. Villeval, J. A. Boyce, C. Martinez-A, G. Marquez, I. Goya, Q. Hamid, et al.
Coordinated Involvement of Mast Cells and T Cells in Allergic Mucosal Inflammation: Critical Role of the CC Chemokine Ligand 1:CCR8 Axis
J. Immunol., August 1, 2007; 179(3): 1740 - 1750.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. C. Jensen, R. Nygaard, S. Thiele, A. Elder, G. Zhu, R. Kolbeck, S. Ghosh, T. W. Schwartz, and M. M. Rosenkilde
Molecular Interaction of a Potent Nonpeptide Agonist with the Chemokine Receptor CCR8
Mol. Pharmacol., August 1, 2007; 72(2): 327 - 340.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Hoshino, Y. I. Kawamura, M. Yasuhara, N. Toyama-Sorimachi, K. Yamamoto, A. Matsukawa, S. A. Lira, and T. Dohi
Inhibition of CCL1-CCR8 Interaction Prevents Aggregation of Macrophages and Development of Peritoneal Adhesions
J. Immunol., April 15, 2007; 178(8): 5296 - 5304.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.